Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9257 |
High Similarity |
NPD2801 |
Approved |
0.8933 |
High Similarity |
NPD1934 |
Approved |
0.8904 |
High Similarity |
NPD1511 |
Approved |
0.8882 |
High Similarity |
NPD3882 |
Suspended |
0.8784 |
High Similarity |
NPD1512 |
Approved |
0.8627 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8611 |
High Similarity |
NPD1510 |
Phase 2 |
0.85 |
High Similarity |
NPD3818 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8462 |
Intermediate Similarity |
NPD943 |
Approved |
0.8452 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8403 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8375 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8375 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8312 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8311 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8302 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8282 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8239 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8239 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8231 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.8188 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8165 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8121 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8105 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8039 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8038 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8027 |
Intermediate Similarity |
NPD447 |
Suspended |
0.8024 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD5402 |
Approved |
0.795 |
Intermediate Similarity |
NPD919 |
Approved |
0.7933 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7888 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7771 |
Intermediate Similarity |
NPD920 |
Approved |
0.7762 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7756 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7756 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7756 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7755 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7736 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7697 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7658 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD6651 |
Approved |
0.76 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7574 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7546 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7532 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3750 |
Approved |
0.75 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7452 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7442 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7405 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7351 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5353 |
Approved |
0.731 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7305 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7286 |
Intermediate Similarity |
NPD228 |
Approved |
0.7279 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7278 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7273 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7235 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7215 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7212 |
Intermediate Similarity |
NPD37 |
Approved |
0.7211 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7208 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7184 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7174 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7152 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7125 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7124 |
Intermediate Similarity |
NPD411 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7103 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7076 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7039 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD824 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7025 |
Intermediate Similarity |
NPD6099 |
Approved |
0.702 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.6994 |
Remote Similarity |
NPD2403 |
Approved |
0.6994 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6993 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.699 |
Remote Similarity |
NPD2899 |
Discontinued |
0.6989 |
Remote Similarity |
NPD6779 |
Approved |
0.6989 |
Remote Similarity |
NPD6781 |
Approved |
0.6989 |
Remote Similarity |
NPD6776 |
Approved |
0.6989 |
Remote Similarity |
NPD6782 |
Approved |
0.6989 |
Remote Similarity |
NPD6780 |
Approved |
0.6989 |
Remote Similarity |
NPD6777 |
Approved |
0.6989 |
Remote Similarity |
NPD6778 |
Approved |
0.6981 |
Remote Similarity |
NPD2346 |
Discontinued |
0.698 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD1019 |
Discontinued |
0.6957 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD1241 |
Discontinued |
0.6894 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.6887 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6878 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6867 |
Remote Similarity |
NPD1201 |
Approved |
0.6867 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6851 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6851 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6836 |
Remote Similarity |
NPD1729 |
Discontinued |
0.6828 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6826 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6821 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD1608 |
Approved |
0.6821 |
Remote Similarity |
NPD3972 |
Approved |
0.6795 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6789 |
Remote Similarity |
NPD7698 |
Approved |
0.6789 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6789 |
Remote Similarity |
NPD7697 |
Approved |
0.6788 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6778 |
Remote Similarity |
NPD8312 |
Approved |
0.6778 |
Remote Similarity |
NPD8313 |
Approved |
0.6774 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.677 |
Remote Similarity |
NPD7266 |
Discontinued |
0.676 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6754 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6754 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6752 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.675 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.675 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6737 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6736 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6728 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6726 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6723 |
Remote Similarity |
NPD2163 |
Approved |
0.6722 |
Remote Similarity |
NPD7549 |
Discontinued |
0.672 |
Remote Similarity |
NPD6534 |
Approved |
0.672 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.672 |
Remote Similarity |
NPD6535 |
Approved |
0.672 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6713 |
Remote Similarity |
NPD74 |
Approved |
0.6713
|
Remote Similarity |
NPD9266 |
Approved |